Thus, in agreement with our previous results these findings strongly suggested that Myo1F deficiency ameliorates the symptoms of DSS-mediated colitis by a mechanism that does not impairs recruitment of monocytes, macrophages and dendritic cells into the inflamed area. Here, MYO1F is linked to colitis.